Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 31.68
+1.75 (5.85%)
Aug 20, 2026, 3:00 PM CST
SHA:603538 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 478.48 | 701.67 | 585.43 | 456.04 | 791.94 | 421.79 |
Trading Asset Securities | 164.41 | 216.82 | 154.44 | 268.65 | 217.38 | 371.38 |
Cash & Short-Term Investments | 642.9 | 918.49 | 739.87 | 724.69 | 1,009 | 793.16 |
Cash Growth | -0.38% | 24.14% | 2.09% | -28.20% | 27.25% | 88.83% |
Accounts Receivable | 459.12 | 378.94 | 331.32 | 320.73 | 187.59 | 222.73 |
Other Receivables | 47.83 | 48.91 | 52.82 | 60.45 | 28.45 | 16.53 |
Receivables | 506.96 | 427.86 | 384.14 | 381.19 | 216.04 | 239.26 |
Inventory | 932.94 | 858.72 | 773.76 | 612.6 | 594.42 | 579.69 |
Prepaid Expenses | - | - | 0.18 | - | - | - |
Other Current Assets | 90.99 | 79.7 | 73.5 | 40.9 | 74.61 | 90.29 |
Total Current Assets | 2,174 | 2,285 | 1,971 | 1,759 | 1,894 | 1,702 |
Property, Plant & Equipment | 1,803 | 1,832 | 1,888 | 1,900 | 1,802 | 1,615 |
Long-Term Investments | 382.88 | 384.42 | 327.4 | 315.32 | 300.11 | 319.59 |
Goodwill | - | - | - | - | - | 22.74 |
Other Intangible Assets | 188.61 | 191.5 | 203.4 | 166.23 | 142.73 | 181.92 |
Long-Term Deferred Tax Assets | 43.99 | 37.99 | 41.16 | 42.67 | 123.18 | 33.27 |
Long-Term Deferred Charges | 58.43 | 52.89 | 44.11 | 55.24 | 50.16 | 41.09 |
Other Long-Term Assets | 82.35 | 68.5 | 175.59 | 184.34 | 107.01 | 85.81 |
Total Assets | 4,733 | 4,852 | 4,651 | 4,424 | 4,419 | 4,001 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 491.76 | 409.95 | 508.18 | 390.99 | 345.45 | 220.92 |
Accrued Expenses | 54.19 | 58.2 | 61.15 | 61.71 | 55.98 | 50.62 |
Short-Term Debt | 603.35 | 697.48 | 479.06 | 486.72 | 465.28 | 425.87 |
Current Portion of Long-Term Debt | 122.61 | 111.55 | 195.54 | 53.83 | 28.44 | 75.65 |
Current Portion of Leases | 3.65 | 3.98 | 2.97 | 2.26 | 3.29 | 3.52 |
Current Income Taxes Payable | 6.4 | 6.42 | 0.09 | 5.36 | 56.92 | 25.83 |
Current Unearned Revenue | 111.69 | 145.49 | 148.88 | 153.09 | 194.92 | 81.06 |
Other Current Liabilities | 129.08 | 151.2 | 190.11 | 224.31 | 211.94 | 263.36 |
Total Current Liabilities | 1,523 | 1,584 | 1,586 | 1,378 | 1,362 | 1,147 |
Long-Term Debt | 39.5 | 678.59 | 651.62 | 743.96 | 675.25 | 727.31 |
Long-Term Leases | 10.76 | 11.15 | 12.35 | 15.69 | 30.34 | 28.03 |
Long-Term Unearned Revenue | 96.78 | 95.26 | 83.18 | 81.48 | 70.57 | 48.67 |
Long-Term Deferred Tax Liabilities | 32.9 | 27.49 | 21.82 | 13.59 | 103.12 | 67.31 |
Other Long-Term Liabilities | 4.76 | 4.76 | 4.85 | 4.85 | 4.85 | 4.85 |
Total Liabilities | 1,707 | 2,402 | 2,360 | 2,238 | 2,246 | 2,023 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 242.81 | 220.63 | 218.75 | 213.41 | 213.38 | 151.32 |
Additional Paid-In Capital | 1,243 | 665.47 | 632.47 | 583.45 | 561.87 | 587.21 |
Retained Earnings | 1,464 | 1,401 | 1,309 | 1,247 | 1,271 | 962.13 |
Treasury Stock | -27.74 | -28.92 | -45.67 | -23.08 | -31.99 | -27.97 |
Comprehensive Income & Other | 10.04 | 77.98 | 77.89 | 75.59 | 71.12 | 78.8 |
Total Common Equity | 2,932 | 2,336 | 2,193 | 2,096 | 2,085 | 1,751 |
Minority Interest | 93.74 | 115.17 | 98.7 | 89.43 | 88.25 | 227.02 |
Shareholders' Equity | 3,026 | 2,451 | 2,291 | 2,186 | 2,173 | 1,979 |
Total Liabilities & Equity | 4,733 | 4,852 | 4,651 | 4,424 | 4,419 | 4,001 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 779.87 | 1,503 | 1,342 | 1,302 | 1,203 | 1,260 |
Net Cash (Debt) | -136.97 | -584.26 | -601.66 | -577.77 | -193.29 | -467.21 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.44 | -1.92 | -1.99 | -1.78 | -0.61 | -1.57 |
Filing Date Shares Outstanding | 339.93 | 308.88 | 306.26 | 298.77 | 298.73 | 295.95 |
Total Common Shares Outstanding | 339.93 | 308.88 | 306.26 | 298.77 | 298.73 | 295.95 |
Working Capital | 651.05 | 700.5 | 385.49 | 381.11 | 532.16 | 555.58 |
Book Value Per Share | 8.63 | 7.56 | 7.16 | 7.02 | 6.98 | 5.92 |
Tangible Book Value | 2,744 | 2,144 | 1,989 | 1,930 | 1,942 | 1,547 |
Tangible Book Value Per Share | 8.07 | 6.94 | 6.50 | 6.46 | 6.50 | 5.23 |
Buildings | 990.3 | 960.33 | 872.69 | 697.36 | 593.92 | 513.49 |
Machinery | 1,287 | 1,281 | 1,230 | 1,087 | 1,054 | 817.08 |
Construction In Progress | 265.36 | 272.26 | 358.36 | 576.39 | 502.88 | 733.82 |